Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.990
+0.030 (1.54%)
Nov 21, 2024, 3:14 PM EST - Market open
Caribou Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 180 | 507 | 383 | 908 | - | - |
| Market Cap Growth | -58.03% | 32.27% | -57.82% | - | - | - |
| Enterprise Value | -77 | 137 | 68 | 473 | - | - |
| Last Close Price | 1.96 | 5.73 | 6.28 | 15.09 | - | - |
| PS Ratio | 15.32 | 14.70 | 27.66 | 94.63 | - | - |
| PB Ratio | 0.63 | 1.38 | 1.27 | 2.34 | - | - |
| P/TBV Ratio | 0.63 | 1.38 | 1.27 | 2.34 | - | - |
| EV/Sales Ratio | - | 3.99 | 4.94 | 49.28 | - | - |
| Debt / Equity Ratio | 0.09 | 0.07 | 0.09 | - | 0.09 | 0.00 |
| Asset Turnover | 0.03 | 0.09 | 0.03 | 0.04 | 0.25 | - |
| Quick Ratio | 7.18 | 11.75 | 8.97 | 14.87 | 1.70 | 5.30 |
| Current Ratio | 7.38 | 11.97 | 9.25 | 15.15 | 1.96 | 5.66 |
| Return on Equity (ROE) | -43.60% | -30.50% | -28.87% | -32.99% | -102.92% | - |
| Return on Assets (ROA) | -25.14% | -18.00% | -16.30% | -17.50% | -46.09% | - |
| Return on Capital (ROIC) | -27.48% | -20.03% | -18.56% | -20.55% | -65.87% | - |
| Earnings Yield | -83.46% | -20.14% | -25.95% | -7.37% | - | - |
| FCF Yield | -73.67% | -20.70% | -25.43% | -3.81% | - | - |
| Buyback Yield / Dilution | -34.02% | -21.39% | -92.02% | -270.47% | -2.05% | - |
| Total Shareholder Return | -34.02% | -21.39% | -92.02% | -270.47% | -2.05% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.